Concord Medical Services (NYSE:CCM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Concord Medical Services (NYSE:CCM) in a research note issued to investors on Friday. The brokerage issued a sell rating on the stock.

Concord Medical Services Trading Down 30.2 %

CCM stock opened at $4.50 on Friday. The company has a quick ratio of 0.46, a current ratio of 0.47 and a debt-to-equity ratio of 1.15. Concord Medical Services has a 52 week low of $3.82 and a 52 week high of $26.70. The business has a 50-day simple moving average of $5.30 and a 200 day simple moving average of $6.63.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.